Skip to main content

This job has expired

You will need to login before you can apply for a job.

Research Associate II, In Vivo Immunology – Preclinical Pharmacology

Employer
Nurix Therapeutics
Location
San Francisco, CA
Start date
Jan 1, 2022

View more

Discipline
Regulatory, Science/R&D, Immunology, Pharmacology
Required Education
Bachelors Degree
Position Type
Full time
Hotbed
Biotech Bay

Job Details


Position

We are seeking a highly skilled and motivated Research Associate to support Nurix’s mission of targeting E3 ubiquitin ligases in the areas of oncology and immunology. The ideal candidate will have expertise in small molecule PK, PD, and efficacy studies in immuno-oncology, autoimmunity, or inflammation. This individual will work closely with our drug discovery project scientists on optimization of novel compounds to support identification of lead compounds, demonstrate vivo efficacy, and characterize ex vivo immune cell function. The candidate must be self-driven, organized, able to work well with project scientists, and able to thrive in an exciting environment in a rapidly-growing company.


 Qualifications

  • B.S. in biology, immunology or related field with 3+ years of industry experience
  • Excellent hands-on in vivo skills: IV, PO dosing, tumor implantation, blood/tissue collection, etc.
  • Experience with tumor models or autoimmune disease models required
  • Proficiency with cell culture preferred
  • Experience with PD biomarker assessment a plus (e.g. Luminex, Western, flow, etc.)
  • Excellent communication and presentation skills
  • Excellent interpersonal skills and ability to work productively in a highly dynamic environment

Fit with Nurix Culture and Values

  • Strong team orientation; highly collaborative; solutions and results-oriented focus
  • Strong scientific curiosity and initiative; hands-on and resourceful
  • Self-driven and enthusiastic with the ability to thrive in a dynamic environment

Company

Nurix Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. Leveraging Nurix’s extensive expertise in E3 ligases together with its proprietary DNA-encoded libraries, Nurix has built DELigase, an integrated discovery platform to identify and advance novel drug candidates targeting E3 ligases, a broad class of enzymes that can modulate proteins within the cell. Nurix’s drug discovery approach is to either harness or inhibit the natural function of E3 ligases within the ubiquitin proteasome system to selectively decrease or increase cellular protein levels.

Nurix’s wholly owned pipeline comprises targeted protein degraders of Bruton’s tyrosine kinase, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, an E3 ligase that regulates T cell activation. Nurix is headquartered in San Francisco, California.

Company info
Website
Phone
415-660-5320
Location
1700 Owens Street
Suite 205
San Francisco
California
94158
US

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert